Biotage

Biotage Intangible Assets

Delisted

The Intangible Assets of Biotage (BIOT.ST) as of Oct 18, 2026 is 765.00 M SEK. In the previous year, Intangible Assets was 755.00 M SEK — a change of 1.32% (higher).

Intangible Assets

765.00 MSEK

YoY

1.32%

Last updated:

Intangible Assets of Biotage is 2024 765.00 M SEK. Intangible Assets of Biotage was 2023 755.00 M SEK. It decreases by 1.32% higher compared to the previous year.

The Biotage Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
118.65 M SEK
Jan 1, 2018
192.65 M SEK
Jan 1, 2019
260.05 M SEK
Jan 1, 2020
250.79 M SEK
Jan 1, 2021
313.00 M SEK
Jan 1, 2022
308.00 M SEK
Jan 1, 2023
755.00 M SEK
Jan 1, 2024
765.00 M SEK
The Biotage Intangible Assets history
YEARIntangible AssetsYoY
765.00 MSEK+1.32%
755.00 MSEK+145.13%
308.00 MSEK-1.60%
313.00 MSEK+24.81%
250.79 MSEK-3.56%
260.05 MSEK+34.98%
192.65 MSEK+62.38%
118.65 MSEK+2.27%
116.02 MSEK+0.73%
115.17 MSEK-7.73%
124.82 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotage Stock analysis

What does Biotage do? Biotage AB is a Swedish company founded in 1983. Since then, the company has become an international leader in the development, manufacturing, and marketing of equipment, chemicals, and accessories for organic and medicinal chemistry, pharmacy, biochemistry, and food analysis. The company's business model is based on the development and marketing of innovative instruments and technologies for analytics and chromatography. Consumables and accessory products are also an important part of the business model. Biotage offers customized solutions tailored to each customer's specific needs. Biotage systems are widely used in the pharmaceutical, biotech, and academic sectors. The company is divided into four main divisions: chromatography, spectroscopy, analytics, and synthesis. In the chromatography division, Biotage offers a wide range of systems for sample preparation and analysis, including flash chromatography systems, HPLC systems, and automation solutions for column development. In the spectroscopy division, Biotage offers systems for molecular structure determination, including NMR spectrometers and FT-IR spectrometers. In the analytics division, the company specializes in mass spectrometry and offers a wide range of instruments and accessories, including HPLC-MS systems, MALDI-TOF systems, and LC-MS applications. In the synthesis division, the focus is on the development and marketing of tools for the synthesis, purification, and analysis of peptides and synthesis kits. Biotage is also known for its wide range of chemicals and accessory products. The company offers a variety of solvents, catalysts, reagents, and separation columns that can be used in organic, pharmaceutical, and biological synthesis. Accessory products include items such as activated carbon filter cartridges or membranes for various chromatography systems. Despite the wide range of products, Biotage has focused on specialized markets, particularly drug research and development, peptide synthesis, and the production of specialty chemicals. In these markets, the devices and chemicals are used to develop and produce medications and important blockbuster compounds. In conclusion, Biotage is a company that focuses on the development and marketing of instruments and technologies for analytics and chromatography. Thanks to its strong market presence and innovative products, the company has become an internationally recognized manufacturer. Biotage is headquartered in Sweden, but its global network of sales and service centers enables global presence and development. Biotage is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotage stock

Intangible Assets of Biotage is 765.00 M SEK in 2024.

Intangible Assets of Biotage changed from 755.00 M SEK to 765.00 M SEK, representing a 1.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Biotage since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Biotage historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Biotage

All Key Metrics — Biotage